Skip to main content

Find Clinical Trials

Home
Conditions
Leukemia

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,421 public trials 1,034 recruiting studies

Refine in advanced search Browse all conditions

Leukemia trial results

Completed

Monoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or Lymphoma

NCT00049712

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +43 more
Locations: University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States

View Trial Details

Completed

Peds SM-THINk: Nursing Interventions to Improve Discharge Outcomes

NCT03539978

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Completed

Liposomal Vincristine Plus Dexamethasone in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

NCT00144963

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Emory University Atlanta, Georgia, United States

University of Chicago Medical Center Chicago, Illinois, United States

University of Texas M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Genetic Study of Familial Acute Lymphoblastic Leukemia

NCT03067584

Conditions: Acute Lymphoblastic Leukemia (ALL), Disease Attributes, Disease Susceptibility, +14 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Completed

Yttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDS

NCT01300572

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +27 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Azacytidine and Lymphocytes in Relapse of AML or MDS After Allogeneic Stem Cell Transplantation.

NCT02017457

Conditions: Acute Myelogenous Leukemia, Bone Marrow Diseases, Disease Attributes, +12 more
Locations: Ziekenhuis Netwerk Antwerpen Antwerp, Belgium

AZ Sint-Jan Brugge Bruges, Belgium

Institut Jules Bordet Brussels, Belgium

Universitair Ziekenhuis Antwerpen Edegem, Belgium

View Trial Details

Completed

Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant

NCT01251575

Conditions: Adult Acute Lymphoblastic Leukemia, Adult Acute Myeloid Leukemia, Adult Diffuse Large B-Cell Lymphoma, +67 more
Locations: Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States

Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States

VA Puget Sound Health Care System Seattle, Washington, United States

Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

A Study to Evaluate the Effect of Ibrutinib on the Pharmacokinetics of Oral Contraceptives, CYP2B6, and CYP3A4 Substrates in Female Participants With B Cell Malignancy

NCT03301207

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations: Pratia MCM Krakow Krakow, Poland

Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu Wroclaw, Poland

Hosp. Univ. Fund. Jimenez Diaz Madrid, Spain

Clinica Univ. de Navarra Pamplona, Spain

View Trial Details

Completed

CX-01 Combined With Azacitidine in the Treatment of Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia

NCT02995655

Conditions: AML, Acute Myeloid Leukemia, Bone Marrow Diseases, +9 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

Validation of Digital-PCR Analysis Through Programmed Imatinib Interruption in PCR Negative CML Patients

NCT01578213

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations: McGill University - Jewish General Hospital Division of Hematology and Department of Oncology Montreal, Quebec, Canada

Charité University of Berlin - Clinic of Medicine - Hematology and Oncology Berlin, Germany

Chaim Sheba Medical Center - Division of Hematology, BMT and CBB Tel Litwinsky, Israel

Azienda Ospedaliero-Universitaria "Policlinico-Vittorio Emanuele" Catania, Italy/Catania, Italy

View all 14 locations

View Trial Details